Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 2,067Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 44TAKEDA PHARMS USA

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
Medlab Asia & Asia Health
Not Confirmed
arrow
Medlab Asia & Asia Health
Not Confirmed

ALOGLIPTIN BENZOATE

US Patent Number : 7807689

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 22271

Patent Use Code : U-1337

Delist Requested :

Patent Use Description : METHOD OF TREATING DIA...

Patent Expiration Date : 2028-06-27

blank

02

arrow
Medlab Asia & Asia Health
Not Confirmed
arrow
Medlab Asia & Asia Health
Not Confirmed

ALOGLIPTIN BENZOATE

US Patent Number : 7807689

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 22271

Patent Use Code : U-1337

Delist Requested :

Patent Use Description : METHOD OF TREATING DIA...

Patent Expiration Date : 2028-06-27

blank

03

arrow
Medlab Asia & Asia Health
Not Confirmed
arrow
Medlab Asia & Asia Health
Not Confirmed

ALOGLIPTIN BENZOATE; PIOGLITAZONE HYDROCHLORIDE

US Patent Number : 8173663

Drug Substance Claim :

Drug Product Claim :

Application Number : 22426

Patent Use Code : U-1338

Delist Requested :

Patent Use Description : METHOD OF TREATING DIA...

Patent Expiration Date : 2025-03-15

blank

04

arrow
Medlab Asia & Asia Health
Not Confirmed
arrow
Medlab Asia & Asia Health
Not Confirmed

ALOGLIPTIN BENZOATE; PIOGLITAZONE HYDROCHLORIDE

US Patent Number : 8173663

Drug Substance Claim :

Drug Product Claim :

Application Number : 22426

Patent Use Code : U-1338

Delist Requested :

Patent Use Description : METHOD OF TREATING DIA...

Patent Expiration Date : 2025-03-15

blank

05

arrow
Medlab Asia & Asia Health
Not Confirmed
arrow
Medlab Asia & Asia Health
Not Confirmed

ALOGLIPTIN BENZOATE; PIOGLITAZONE HYDROCHLORIDE

US Patent Number : 8173663

Drug Substance Claim :

Drug Product Claim :

Application Number : 22426

Patent Use Code : U-1338

Delist Requested :

Patent Use Description : METHOD OF TREATING DIA...

Patent Expiration Date : 2025-03-15

blank

06

arrow
Medlab Asia & Asia Health
Not Confirmed
arrow
Medlab Asia & Asia Health
Not Confirmed

ALOGLIPTIN BENZOATE; PIOGLITAZONE HYDROCHLORIDE

US Patent Number : 7807689

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 22426

Patent Use Code : U-1337

Delist Requested :

Patent Use Description : METHOD OF TREATING DIA...

Patent Expiration Date : 2028-06-27

blank

07

arrow
Medlab Asia & Asia Health
Not Confirmed
arrow
Medlab Asia & Asia Health
Not Confirmed

ALOGLIPTIN BENZOATE; PIOGLITAZONE HYDROCHLORIDE

US Patent Number : 8173663

Drug Substance Claim :

Drug Product Claim :

Application Number : 22426

Patent Use Code : U-1338

Delist Requested :

Patent Use Description : METHOD OF TREATING DIA...

Patent Expiration Date : 2025-03-15

blank

08

arrow
Medlab Asia & Asia Health
Not Confirmed
arrow
Medlab Asia & Asia Health
Not Confirmed

ALOGLIPTIN BENZOATE; PIOGLITAZONE HYDROCHLORIDE

US Patent Number : 8173663

Drug Substance Claim :

Drug Product Claim :

Application Number : 22426

Patent Use Code : U-1338

Delist Requested :

Patent Use Description : METHOD OF TREATING DIA...

Patent Expiration Date : 2025-03-15

blank

09

arrow
Medlab Asia & Asia Health
Not Confirmed
arrow
Medlab Asia & Asia Health
Not Confirmed

ALOGLIPTIN BENZOATE; PIOGLITAZONE HYDROCHLORIDE

US Patent Number : 7807689

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 22426

Patent Use Code : U-1337

Delist Requested :

Patent Use Description : METHOD OF TREATING DIA...

Patent Expiration Date : 2028-06-27

blank

10

arrow
Medlab Asia & Asia Health
Not Confirmed
arrow
Medlab Asia & Asia Health
Not Confirmed

ALOGLIPTIN BENZOATE; PIOGLITAZONE HYDROCHLORIDE

US Patent Number : 8173663

Drug Substance Claim :

Drug Product Claim :

Application Number : 22426

Patent Use Code : U-1338

Delist Requested :

Patent Use Description : METHOD OF TREATING DIA...

Patent Expiration Date : 2025-03-15

blank